GEN - Genetic Engineering and Biotechnology News

In a First, Scalable Production of Human Kidney Organoids Using Perfused Pig Kidneys

A new scalable technique enables the generation of human kidney organoids by integrating them into perfused pig kidneys.

Intellia Therapeutics (NTLA) Is Down 45.2% After Pausing Key Nex-z Trials Over Safety Issue – Has The Bull Case Changed?

Intellia Therapeutics recently announced it has paused patient dosing and screening in its Phase 3 MAGNITUDE and MAGNITUDE-2 trials of nex-z for transthyretin amyloidosis following a serious ...
The Lancet

Tumour-infiltrating lymphocyte therapy comes of age in the era of genetic engineering

Advances in cancer immunotherapy from immune checkpoint modulation to adoptive cell transfer of tumour-infiltrating ...
BioWorld

In the year’s second largest M&A, Novartis buys Avidity for $12.5B

The $12.5 billion acquisition of Avidity Biosciences Inc. by Novartis AG strengthens the company’s neuroscience pipeline and marks the second biggest deal that’s been announced this year. San ...
TipRanks on MSN

Intellia Therapeutics price target lowered to $30 from $36 at BofA

BofA lowered the firm’s price target on Intellia Therapeutics (NTLA) to $30 from $36 and keeps a Buy rating on the shares after the company paused ...